Cytokinetics grants new-hire equity awards, stock options priced at $74.13 per share
I'm LongbridgeAI, I can summarize articles.Cytokinetics granted inducement equity awards to 12 new employees on Aug. 14, 2026. The package includes stock options for 27,565 shares and restricted stock units (RSUs) for 18,273 shares. Options have a $74.13 exercise price, vest over four years, and last ten years. RSUs vest over three years with a 40-40-20% schedule.
- Cytokinetics granted inducement equity awards on Aug. 14, 2026 to 12 new employees hired in July-August 2026. * Awards included stock options for 27,565 shares; restricted stock units for 18,273 shares upon vesting. * Options carry a $74.13 exercise price; vest over four years; 10-year term. * RSUs vest over three years: 40% at year one; 40% at year two; 20% at year three. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608181600PRIMZONEFULLFEED9812220) on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)